-
17 August 2026 11:00:52
- Source: Sharecast
|
|
|
|
|
|
|
|
17 August 2026 |
|
|
|
|
|
|
Taylor Wimpey plc |
|
||||
|
Transaction in Own Shares |
|
||||
|
|
|
||||
|
Taylor Wimpey plc (the "Company") announces today that, acting through its corporate stockbroker, Merrill Lynch International, it has purchased the following number of the Company's ordinary shares of 1 pence each in the period from 10 August 2026 to 14 August 2026. |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date |
Number of shares purchased |
Highest price paid (GBp) |
Lowest price paid (GBp) |
Volume weighted average price (GBp) |
Trading Venue |
|
10/08/26 |
535,000 |
84.50 |
82.3000 |
83.31 |
XLON |
|
11/08/26 |
550,000 |
84.46 |
82.06 |
83.79 |
XLON |
|
12/08/26 |
540,000 |
87.24 |
85.12 |
85.97 |
XLON |
|
13/08/26 |
540,000 |
87.54 |
84.88 |
86.75 |
XLON |
|
14/08/26 |
516,281 |
86.80 |
85.32 |
85.93 |
XLON |
|
|
|
|
|
|
|
|
The Company intends to cancel the purchased shares. |
|
||||
|
Following the above transaction(s), the Company holds 31,819,246 of its ordinary shares in treasury and has 3,483,175,497 shares in issue (excluding treasury shares). |
|||||
|
|
|
|
|
|
|
|
Accordingly, the total number of voting rights in the Company will be 3,483,175,497. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. |
|||||
|
|
|
|
|
|
|
|
Individual transactions: http://www.rns-pdf.londonstockexchange.com/rns/9606Q_1-2026-8-17.pdf |
|||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.